Autoinflammatory & rare systemic diseases

Expansion and surface makers of age-associated B cells in IgG4-related disease

Clin Exp RheumatolPublished Mechanistic study

Authors' conclusion

ABCs were expanded both in the peripheral blood and affected tissues of patients with IgG4-RD as well as in the lungs of LAT mice, indicating the potential roles of ABCs in IgG4-RD pathogenesis.

Study context

Population
Patients with IgG4-related disease (IgG4-RD), patients with other autoimmune diseases and healthy controls; LatY136F knock-in (LAT) IgG4-RD mouse model
Participants
51 / 18 / 34 / 61
Comparison
Untreated IgG4-RD vs IgG4-RD in remission vs other autoimmune diseases vs age- and sex-matched healthy controls (HCs)
  • Untreated IgG4-RDn = 51
  • IgG4-RD in remissionn = 18
  • Other autoimmune diseasesn = 34
  • HCsn = 61reference
Outcome
Expression of ABCs (CD21-T-bet+CD11c+ in CD19+ B cells) and their surface markers
Methodological detailsflow cytometry, immunofluorescence, LatY136F knock-in mouse model
  • Flow cytometry
  • Immunofluorescence
  • LatY136F knock-in mouse model

Main finding

As reported in the abstract

  • Percentages and absolute numbers of ABCs in CD19+ B cells raised remarkably in untreated IgG4-RD vs HC, and reduced significantly after treatment
  • Percentage of CD27+ABCs, DN2 B cells and activated naive B cells higher in IgG4-RD than in HCs and multiple autoimmune diseases; comparable with SLE
  • CD19+CD21-CD11c+ B cells of IgG4-RD vs HC: upregulated CD86, TACI, CD38; downregulated CXCR3
  • In IgG4-RD, CD19+CD21-CD11c+ vs CD19+CD21-CD11c- B cells: higher CD80, CXCR3, TACI, CD95, BAFF-R; lower CD86, CD27, CD38, CXCR5
  • ABCs (CD11c+T-bet+ in B220+ cells) increased significantly in lungs of LAT vs wild type (WT) mice

Original publication

Expansion and surface makers of age-associated B cells in IgG4-related disease. Clin Exp Rheumatol. Published 2 February 2023. doi:10.55563/clinexprheumatol/1b9d13

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.